Fiore Cannabis Ltd.
Fiore Cannabis Ltd.
Your view on FIORF
Overview
What the company does, where it operates, and who runs it.
About Fiore Cannabis Ltd.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Erik Anderson
- Headquarters
- RPO Orchard Park, Kelowna, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Erik Anderson
- Headquarters
- RPO Orchard Park, Kelowna, BC, CA
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in October 2020.
The company was incorporated in 2007 and is headquartered in Kelowna, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Fiore Cannabis Ltd., and the rating behind it. FIORF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Fiore Cannabis Ltd.. Starting points for Fiore Cannabis Ltd.: EPS -$0.06, beta 1.31 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Fiore Cannabis Ltd.. Fiore Cannabis Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Fiore Cannabis Ltd.. Trailing twelve-month EPS for Fiore Cannabis Ltd. stands at -$0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Fiore Cannabis Ltd.. Fiore Cannabis Ltd. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Fiore Cannabis Ltd. valued side by side against its closest peers. Fiore Cannabis Ltd. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Fiore Cannabis Ltd., and how their positions are changing. At a $1,971 market value, institutional positions materially move Fiore Cannabis Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Fiore Cannabis Ltd. executives and directors. Shares of Fiore Cannabis Ltd. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Fiore Cannabis Ltd.. Fiore Cannabis Ltd. is a $1,971 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Fiore Cannabis Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Fiore Cannabis Ltd.. Coverage tracks Fiore Cannabis Ltd. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.